Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC

被引：0

作者：

Shunichi Sugawara

Kazuhiko Nakagawa

Nobuyuki Yamamoto

Hiroshi Nokihara

Yuichiro Ohe

Makoto Nishio

Toshiaki Takahashi

Koichi Goto

Makoto Maemondo

Yukito Ichinose

Takashi Seto

Hiroshi Sakai

Akihiko Gemma

Fumio Imamura

Masato Shingyoji

Hideo Saka

Akira Inoue

Koji Takeda

Isamu Okamoto

Katsuyuki Kiura

Satoshi Morita

Tomohide Tamura

机构：

[1] Sendai Kousei Hospital,Department of Pulmonary Medicine

[2] Kindai University,Department of Medical Oncology, Faculty of Medicine

[3] Wakayama Medical University,Third Department of Internal Medicine

[4] National Cancer Center Hospital,Department of Thoracic Oncology

[5] The Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Thoracic Medical Oncology

[6] Shizuoka Cancer Center,Division of Thoracic Oncology

[7] National Cancer Center Hospital East,Department of Thoracic Oncology

[8] Miyagi Cancer Center,Department of Respiratory Medicine

[9] Clinical Research Institute,Department of Cancer Information Research, National Kyushu Cancer Center

[10] National Kyushu Cancer Center,Department of Thoracic Oncology

[11] Saitama Cancer Center,Department of Thoracic Oncology

[12] Nippon Medical School,Department of Pulmonary Medicine and Oncology, Graduate School of Medicine

[13] Osaka International Cancer Institute,Department of Thoracic Oncology

[14] Chiba Cancer Center,Division of Respirology

[15] National Hospital Organization Nagoya Medical Center,Department of Respiratory Medicine and Medical Oncology

[16] Tohoku University School of Medicine,Department of Palliative Medicine

[17] Osaka City General Hospital,Department of Medical Oncology

[18] Kyushu University,Research Institute for Diseases of the Chest, Graduate School of Medical Sciences

[19] Okayama University Graduate School of Medicine,Department of Hematology, Oncology, and Respiratory Medicine

[20] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics

[21] St Luke’s International Hospital,Thoracic Center

来源：

International Journal of Clinical Oncology | 2019年 / 24卷

关键词：

Tegafur–gimeracil–oteracil; Second line; Third line; Chemotherapy; Japan; Phase III;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：485 / 493

页数：8

共 50 条

[41] A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancer
Takigawa, Nagio
Kiura, Katsuyuki
Hotta, Katsuyuki
Hosokawa, Shinobu
Nogami, Naoyuki
Aoe, Keisuke
Gemba, Kenichi
Fujiwara, Keiichi
Harita, Shingo
Takemoto, Mitsuhiro
Himei, Kengo
Shinkai, Tetsu
Fujiwara, Yoshirou
Takata, Saburo
Tabata, Masahiro
Kanazawa, Susumu
Tanimoto, Mitsune
LUNG CANCER, 2011, 71 (01) : 60 - 64
[42] A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients
Satoshi Yoda
Kenzo Soejima
Hiroyuki Yasuda
Katsuhiko Naoki
Ichiro Kawada
Hideo Watanabe
Ichiro Nakachi
Ryosuke Satomi
Sohei Nakayama
Sinnosuke Ikemura
Hideki Terai
Takashi Sato
Maiko Morosawa
Koichiro Asano
Cancer Chemotherapy and Pharmacology, 2011, 67 : 717 - 722
[43] Feasibility Study of Adjuvant Chemotherapy of S-1 and Carboplatin for Completely Resected Non-Small Cell Lung Cancer
Komazaki, Yoshitoshi
Sakashita, Hiroyuki
Furuiye, Masashi
Fujie, Toshihide
Tamaoka, Meiyo
Sumi, Yuki
Miyazaki, Yasunari
Kojima, Katsuo
Jin, Yasuto
Inase, Naohiko
CHEMOTHERAPY, 2013, 59 (01) : 35 - 41
[44] A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer
Ikemura, Shinnosuke
Naoki, Katsuhiko
Yasuda, Hiroyuki
Kawada, Ichiro
Yoda, Satoshi
Terai, Hideki
Sato, Takashi
Ishioka, Kota
Arai, Daisuke
Ohgino, Keiko
Kamata, Hirofumi
Miyata, Jun
Kabata, Hiroki
Betsuyaku, Tomoko
Soejima, Kenzo
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (04) : 356 - 361
[45] A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer
Sculier, Jean-Paul
Lafitte, Jean-Jacques
Berghmans, Thierry
Meert, Anne-Pascale
Scherpereel, Arnaud
Roelandts, Martine
Van Cutsem, Olivier
Colinet, Benoit
Bonduelle, Yves
Giner, Vicente
Paesmans, Marianne
Leclercq, Nathalie
Van Houtte, Paul
LUNG CANCER, 2018, 117 : 32 - 37
[46] The Efficacy of S-1 in the Third or More Than Line Treatment of Advanced Non-Small Cell Lung Cancer Patients
Lin, C.
Wang, W.
Zhu, Y.
Du, K.
Wang, W.
Xu, C.
Fang, M.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1073 - S1073
[47] FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer
Cortinovis, D. L.
Andriani, F.
Livio, A.
Fabbri, A.
Perrone, F.
Marcomini, B.
Pilotti, S.
Mariani, L.
Bidoli, P.
Bajetta, E.
Roz, L.
Sozzi, G.
CURRENT CANCER DRUG TARGETS, 2008, 8 (05) : 342 - 348
[48] Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice - results from the ElderTac study
Brueckl, Wolfgang M.
Achenbach, H. Jost
Ficker, Joachim H.
Schuette, Wolfgang
BMC CANCER, 2018, 18
[49] A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer
Yoshimura, Akihiro
Chihara, Yusuke
Date, Koji
Tamiya, Nobuyo
Takemura, Yoshizumi
Imabayashi, Tatsuya
Kaneko, Yoshiko
Yamada, Tadaaki
Ueda, Mikio
Arimoto, Taichiro
Uchino, Junji
Iwasaki, Yoshinobu
Takayama, Koichi
ONCOLOGIST, 2019, 24 (04) : 459 - E131
[50] IMpower210: A phase III study of second-line atezolizumab vs. docetaxel in East Asian patients with non-small cell lung cancer
Wu, Yi-Long
Lu, Shun
Chen, Gongyan
He, Jianxing
Feng, Jifeng
Zhang, Yiping
Jiang, Liyan
Pan, Hongming
Chang, Jianhua
Fang, Jian
Cai, Amy
Bu, Lilian
Shi, Jane
Xia, Jinjing
CHINESE JOURNAL OF CANCER RESEARCH, 2024, 36 (02)

← 1 2 3 4 5 →